What's a Doctor to Do? Balloon, Stents, Drugs, Drills, and Treadmills Are We Closer to the Optimal Algorithm?

JACC: Cardiovascular Interventions

Volumn 8, Issue 8, 2015, Pages 1113-1114

  Jaff, Michael R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

atherectomy; drug coated balloon; peripheral artery disease; stent

Indexed keywords

ANGIOPLASTY CATHETER; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; CRITICAL LIMB ISCHEMIA; DRUG ELUTING CARDIOVASCULAR STENT; ECHOGRAPHY; EDITORIAL; INTERMITTENT CLAUDICATION; INTRAVASCULAR ULTRASOUND; KNOWLEDGE BASE; MEDICAL DECISION MAKING; MULTICENTER STUDY (TOPIC); PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVASCULARIZATION; TREADMILL; DEVICES; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FEMALE; FEMORAL ARTERY; HUMAN; MALE; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY;

DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY;

EID: 84937714425     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.05.003     Document Type: Editorial

References (9)

1. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
2. G. Tepe, J. Laird, P. Schneider, and et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial Circulation 131 2015 495 502
3. O. Iida, M. Takahara, Y. Soga, and et al. 1-year results of the zephyr registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): predictors of restenosis J Am Coll Cardiol Intv 8 2015 1105 1112
4. M.R. Patel, M.S. Conte, D.E. Cutlip, and et al. Evaluation and treatment of lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium J Am Coll Cardiol 65 2015 931 941
5. Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes (LIBERTY). ClinicalTrials.gov website. Available at: https://clinicaltrials.gov/ct2/show/NCT01855412?term=LIBERTY&rank=3. Accessed April 14, 2015.
6. Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST-CLI). ClinicalTrials.gov website. Available at: https://clinicaltrials.gov/ct2/show/NCT02060630?term=BEST+CLI&rank=1. Accessed April 14, 2015.
7. T.P. Murphy, D.E. Cutlip, J.G. Regensteiner, and et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial Circulation 125 2012 130 139
8. T.P. Murphy, D.E. Cutlip, J.G. Regensteiner, and et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral arterial disease: the CLEVER study J Am Coll Cardiol 65 2015 999 1009
9. H. Reinecke, M. Unrath, E. Freisinger, and et al. Peripheral arterial disease and critical limb ischemia: still poor outcomes and lack of guidelines adherence Eur Heart J 36 2015 932 938